These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32012897)

  • 1. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.
    Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ
    Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretome of bone marrow mesenchymal stromal cells cultured in a dynamic system induces neuroprotection and modulates microglial responsiveness in an α-synuclein overexpression rat model.
    Marques CR; Campos J; Sampaio-Marques B; Antunes FF; Dos Santos Cunha RM; Silva D; Barata-Antunes S; Lima R; Fernandes-Platzgummer A; da Silva CL; Sousa RA; Salgado AJ
    Cytotherapy; 2024 Jul; 26(7):700-713. PubMed ID: 38483360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
    Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
    J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
    Suzuki S; Kawamata J; Iwahara N; Matsumura A; Hisahara S; Matsushita T; Sasaki M; Honmou O; Shimohama S
    Neurosci Lett; 2015 Jan; 584():276-81. PubMed ID: 25449872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model.
    Mendes-Pinheiro B; Anjo SI; Manadas B; Da Silva JD; Marote A; Behie LA; Teixeira FG; Salgado AJ
    Front Bioeng Biotechnol; 2019; 7():294. PubMed ID: 31737616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.
    Lee JY; Kim HS; Kim SH; Kim HS; Cho BP
    Tissue Eng Regen Med; 2020 Feb; 17(1):67-80. PubMed ID: 31970698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
    Cucarián JD; Berrío JP; Rodrigues C; Zancan M; Wink MR; de Oliveira A
    J Neurosci Res; 2019 Sep; 97(9):1095-1109. PubMed ID: 31119788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
    Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D
    Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
    Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
    BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Administration of Extracellular Vesicles Derived from Human Teeth Stem Cells Improves Motor Symptoms and Normalizes Tyrosine Hydroxylase Expression in the Substantia Nigra and Striatum of the 6-Hydroxydopamine-Treated Rats.
    Narbute K; Piļipenko V; Pupure J; Dzirkale Z; Jonavičė U; Tunaitis V; Kriaučiūnaitė K; Jarmalavičiūtė A; Jansone B; Kluša V; Pivoriūnas A
    Stem Cells Transl Med; 2019 May; 8(5):490-499. PubMed ID: 30706999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of bone marrow-derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease.
    Mahendru D; Jain A; Bansal S; Malik D; Dhir N; Sharma AR; Sarma P; Prakash A; Nahar U; Bhatia A; Bhattacharyya S; Medhi B
    Regen Med; 2021 Oct; 16(10):915-930. PubMed ID: 34553608
    [No Abstract]   [Full Text] [Related]  

  • 16. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
    Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
    Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Parkinson's Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration.
    Mendes-Pinheiro B; Campos J; Marote A; Soares-Cunha C; Nickels SL; Monzel AS; Cibrão JR; Loureiro-Campos E; Serra SC; Barata-Antunes S; Duarte-Silva S; Pinto L; Schwamborn JC; Salgado AJ
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.
    Mendes-Pinheiro B; Teixeira FG; Anjo SI; Manadas B; Behie LA; Salgado AJ
    Stem Cells Transl Med; 2018 Nov; 7(11):829-838. PubMed ID: 30238668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionating stem cells secretome for Parkinson's disease modeling: Is it the whole better than the sum of its parts?
    Vilaça-Faria H; Marote A; Lages I; Ribeiro C; Mendes-Pinheiro B; Domingues AV; Campos J; Lanceros-Mendez S; Salgado AJ; Teixeira FG
    Biochimie; 2021 Oct; 189():87-98. PubMed ID: 34182001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.